ArticlePsychopharmacology2021

GPR40 receptor agonist TAK-875 improves cognitive deficits and reduces β-amyloid production in APPswe/PS1dE9 mice.

Chao Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.